Search

everythinglearnresearchcommunity

for

Search:↓

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Caffeine penetrates skin quickly through open hair follicles, but less through closed ones, with levels becoming equal after 22 hours.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

Cynatine HNS improves hair and nail quality in 90 days.

Diversifying tea products can boost profits and meet global market demands.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

New methods for skin and nerve regeneration can improve healing and feeling after burns.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.